Difference between revisions of "Phosphatase Subfamily PRL"

From PhosphataseWiki
Jump to: navigation, search
(References)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
[[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Fold_CC1|Fold CC1]]:  [[Phosphatase_Superfamily_CC1|Superfamily CC1]]: [[Phosphatase_Family_DSP|Family DSP]]: [[Phosphatase_Subfamily_PRL|Subfamily PRL]]
+
[[Phosphatase classification|Phosphatase Classification]]: [[Phosphatase_Fold_CC1|Fold CC1]]:  [[Phosphatase_Superfamily_CC1|Superfamily CC1]]: [[Phosphatase_Family_DSP|Family DSP]]: [[Phosphatase_Subfamily_PRL|Subfamily PRL]] (PTP4A)
 
+
 
+
  
 
=== Evolution ===
 
=== Evolution ===
Line 11: Line 9:
  
 
=== Function ===  
 
=== Function ===  
PRL is short for Phosphatases of Regenerating Liver. There are three PRLs in human, PRL1, PRL2, PRL3, all of which have been identified as key contributors to metastasis in several human cancers <cite>tremblay14, Von-Hoff06</cite>.  The molecular mechanisms of PRL phosphatases is reviewed at here <cite>kohn12</cite> in 2012, but it may play other roles as more works are going-on. For example. deletion of PRL3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice <cite>Cramer15</cite>.
+
PRL is short for Phosphatases of Regenerating Liver. There are three PRLs in human, PRL1, PRL2, PRL3, all of which have been identified as key contributors to metastasis in several human cancers <cite>tremblay14, Von-Hoff06</cite>.  The molecular mechanisms of PRL phosphatases is reviewed at here <cite>kohn12</cite> in 2012.  
 +
 
 +
PRL3 is implicated in cancer. For instance, deletion of PRL3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice <cite>Cramer15</cite>. PRL3 (PTP4A3) independently predicts metastasis and survival in upper tract urothelial carcinoma treated with radical nephroureterectomy <cite></cite>.
  
 
=== References ===
 
=== References ===
Line 19: Line 19:
 
#tremblay14 pmid=24632616
 
#tremblay14 pmid=24632616
 
#kohn12 pmid=22413991
 
#kohn12 pmid=22413991
 +
#Yeh15 pmid=26070892
 
</biblio>
 
</biblio>

Revision as of 18:25, 15 June 2015

Phosphatase Classification: Fold CC1: Superfamily CC1: Family DSP: Subfamily PRL (PTP4A)

Evolution

PRL subfamily is present in animals, amoeba, and many basal eukaryotes, but is absent from fungi and plants (unpublish data from gOrtholog).

Domain

PRL has a single domain: phosphatase domain.

Function

PRL is short for Phosphatases of Regenerating Liver. There are three PRLs in human, PRL1, PRL2, PRL3, all of which have been identified as key contributors to metastasis in several human cancers [1, 2]. The molecular mechanisms of PRL phosphatases is reviewed at here [3] in 2012.

PRL3 is implicated in cancer. For instance, deletion of PRL3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice [4]. PRL3 (PTP4A3) independently predicts metastasis and survival in upper tract urothelial carcinoma treated with radical nephroureterectomy [].

References

  1. Hardy S, Uetani N, Wong N, Kostantin E, Labbé DP, Bégin LR, Mes-Masson A, Miranda-Saavedra D, and Tremblay ML. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis. Oncogene. 2015 Feb 19;34(8):986-95. DOI:10.1038/onc.2014.33 | PubMed ID:24632616 | HubMed [tremblay14]
  2. Stephens BJ, Han H, Gokhale V, and Von Hoff DD. PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther. 2005 Nov;4(11):1653-61. DOI:10.1158/1535-7163.MCT-05-0248 | PubMed ID:16275986 | HubMed [Von-Hoff06]
  3. Rios P, Li X, and Köhn M. Molecular mechanisms of the PRL phosphatases. FEBS J. 2013 Jan;280(2):505-24. DOI:10.1111/j.1742-4658.2012.08565.x | PubMed ID:22413991 | HubMed [kohn12]
  4. Cramer JM, Zimmerman MW, Thompson T, Homanics GE, Lazo JS, and Lagasse E. Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. Stem Cell Res. 2014 Jul;13(1):164-171. DOI:10.1016/j.scr.2014.05.004 | PubMed ID:24950307 | HubMed [Cramer15]
  5. Yeh HC, Li CC, Huang CN, Hour TC, Yeh BW, Li WM, Liang PI, Chang LL, Li CF, and Wu WJ. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. J Urol. 2015 Nov;194(5):1449-55. DOI:10.1016/j.juro.2015.05.101 | PubMed ID:26070892 | HubMed [Yeh15]
All Medline abstracts: PubMed | HubMed